5-HTP efficacy and contraindications | Zendy

Marty Hinz | Zendy; Alvin Stein | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

5-HTP efficacy and contraindications

Author(s) -

Marty Hinz,

Alvin Stein

Publication year - 2012

Publication title -

neuropsychiatric disease and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.819

H-Index - 67

eISSN - 1178-2021

pISSN - 1176-6328

DOI - 10.2147/ndt.s33259

Subject(s) - medicine , serotonin , depression (economics) , psychiatry , intensive care medicine , receptor , economics , macroeconomics

L-5-hydroxytryptophan (5-HTP) is the immediate precursor of serotonin. It is readily synthesized into serotonin without biochemical feedback. This nutrient has a large and strong following who advocate exaggerated and inaccurate claims relating to its effectiveness in the treatment of depression and a number of other serotonin-related diseases. These assertions are not supported by the science. Under close examination, 5-HTP may be contraindicated for depression in some of the very patients for whom promoters of 5-HTP advocate its use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research